Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.
Also called NCT05172765
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT05172765
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT05172765. Randomized; double masking; primary purpose treatment. Start 2022-09-14 (actual); primary completion 2025-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- Transcutaneous Electrical Nerve Stimulation Device
- Lead sponsor
- University of Oklahoma
Record details
- Record id
cardio:ct-nct05172765- Content hash
85a20afd911a84d0fc16465759f0693fd2d3112c2572181c15f2e4d606de2619